1.
Saidy AO, Altmann B, van Heteren P, Stelljes M, Lenz G, Marx J, Hasenkamp J, Stölzel F, Dreger P, Mueller LP, Hilgendorf I, Illerhaus G, Kobbe G, Schroers R, Hänel M, Fuhrmann S, Linke K, Koehler C, Ott G, Schmitz N, Ziepert M, Glass B. Allogeneic stem cell transplantation after myeloablative conditioning with fludarabine, thiotepa, and cyclophosphamide in relapsed or refractory aggressive B-cell and T-cell lymphomas: results of the prospective ASTRAL study. haematol [Internet]. 2020Sep.10 [cited 2026Sep.16];. Available from: https://haematologica.org/article/view/14366